alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1**

 

CERTIFICATION

 

I, Theodore R. Maloney, Chief Executive Officer ofMediCor Ltd. (the “Registrant”), certify that:

 

1.             I have reviewed this Quarterly Report on Form 10-QSBof the Registrant;

 

2.             Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

 

3.             Based on my knowledge, the financialstatements, and other financial information included in this report, fairlypresent in all material respects the financial condition, results of operationsand cash flows of the Registrant as of, and for, the periods presented in thisreport;

 

4.             The Registrant’s other certifying officersand I are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))for the Registrant and have:

 

(a)     Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to theRegistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisreport is being prepared;

 

(b)     Evaluated the effectiveness of the Registrant’sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of theend of the period covered by this report based on such evaluation; and

 

(c)     Disclosed in this report any change in theRegistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarterin the case of this annual report) that has materially affected, or is likelyto materially affect, the Registrant’s internal control over financialreporting; and

 

5.             TheRegistrant’sother certifying officers and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the Registrant’sauditors and the audit committee of Registrant’s board of directors (or personsperforming the equivalent functions):

 

(a)     All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the Registrant’sability to record, process, summarize and report financial information; and

 

(b)     Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theRegistrant’s internal control over financial reporting.

 

 
| Dated: February 6, 2006  |
|-------------------------------|
|                          |
| /s/ Theodore R. Maloney       |   |
| Theodore R. Maloney,          |
| Chief Executive Officer       |
| (Principal Executive Officer) |

 

----
**THE SUPREME COURT OF TEXAS**

**Post Office Box 12248**

**Austin, Texas 78711**

**(512) 463-1312**

May 20, 2005

Mr. Jack G. Carnegie

Jones Day

717 Texas Avenue, Suite 3300

Houston, TX 77002-2900

Mr. John Fellas

Hughes Hubbard & Reed LLP

One Battery Park Plaza

New York, NY 10004-1482

Mr. John D. White

Jones Walker Waechter Poitevent 

Carrere & Denegre

10001 Woodloch Forest Drive, Suite 350

The Woodlands, TX 77380

RE:Case Number:  03-1129

Court of Appeals Number:  01-02-01246-CV

Trial Court Number:  2002-47663

Style:IN RE  KELLOGG  BROWN & ROOT, INC.

Dear Counsel:

Today, the Supreme Court of Texas delivered the enclosed opinion in the above-referenced cause.  (Justice Johnson not sitting)

Sincerely,

Andrew Weber, Clerk

by Gena Pelham, Deputy Clerk

Enclosure

**Case No. 03-1129Page 1**
Exhibit
32.2





Certification
of Principal Financial Officer Regarding Periodic Report Containing


Financial
Statements pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906
of


the
Sarbanes-Oxley Act of 2002




I, Bruce
W. Elder, the Principal Financial Officer of Crescent Financial Corporation, in
compliance with 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, hereby certify that, (i) the Form 10-Q filed by
Crescent Financial Corporation (the "Issuer") for the quarter ended June 30,
2010, fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and (ii) the information contained in that
report fairly presents, in all material respects, the financial condition and
results of operations of the Issuer on the dates and for the periods presented
therein.




Date: August
      12, 2010
              
              /s/
      Bruce W. ElderBruce
      W. ElderPrincipal
      Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       6,770,935
<SECURITIES>                                         0
<RECEIVABLES>                                1,618,437
<ALLOWANCES>                                    40,000
<INVENTORY>                                  6,979,323
<CURRENT-ASSETS>                            16,384,387
<PP&E>                                      11,487,948
<DEPRECIATION>                               2,414,939
<TOTAL-ASSETS>                              25,885,088
<CURRENT-LIABILITIES>                        5,632,489
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    17,689,957
<OTHER-SE>                                   1,487,180
<TOTAL-LIABILITY-AND-EQUITY>                25,885,088
<SALES>                                      7,521,026
<TOTAL-REVENUES>                             7,521,026
<CGS>                                        5,579,184
<TOTAL-COSTS>                                  975,466
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (34,134)
<INCOME-PRETAX>                              1,000,510
<INCOME-TAX>                                   385,662
<INCOME-CONTINUING>                            614,848
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   614,848
<EPS-PRIMARY>                                      .16
<EPS-DILUTED>                                      .16
        

</TABLE>
In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * * *

COLLEEN DOTSON, * No. 15-93V

* Special Master Christian J. Moran

Petitioner, *

*

v. *

* Filed: October 16, 2015

SECRETARY OF HEALTH *

AND HUMAN SERVICES, * Stipulation; influenza vaccine;

* shoulder; adhesive capsulitis; bursitis.

Respondent. *

*

* * * * * * * * * * * * * * * * * * * * * * 

Maximillian J. Muller, Muller Brazil, LLP, Philadelphia, PA, for Petitioner;

Heather L. Pearlman, U.S. Dep’t of Justice, Washington, DC, for Respondent.

UNPUBLISHED DECISION1

On October 13, 2015, the parties filed a joint stipulation concerning the 

petition for compensation filed by Colleen Dotson on January 29, 2015. In her

petition, petitioner alleged that the influenza vaccine she received on or about 

October 24, 2012 caused her to suffer a shoulder injury including adhesive 

capsulitis and bursitis, with residual effects lasting more than six months. 

Petitioner represents that there has been no prior award or settlement of a civil 

action for damages on her behalf as a result of his condition.

Respondent denies that any of the vaccines that petitioner received either 

caused or significantly aggravated petitioner’s shoulder injuries or any other injury 

or condition. 

 

1 The E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 

2002), requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), 

the parties have 14 days to file a motion proposing redaction of medical information or other 

information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special 

master will appear in the document posted on the website.
2

Nevertheless, the parties agree to the joint stipulation, attached hereto as 

Appendix A. The undersigned finds said stipulation reasonable and adopts it as the 

decision of the Court in awarding damages, on the terms set forth therein.

Damages awarded in that stipulation include:

A lump sum payment of $75,000.00 in the form of a check payable to 

petitioner, Colleen Dotson. This amount represents compensation for 

all damages that would be available under 42 U.S.C. § 300aa-15(a). 

In the absence of a motion for review filed pursuant to RCFC, Appendix B, 

the clerk is directed to enter judgment in case 15-93V according to this decision 

and the attached stipulation.2

Any questions may be directed to my law clerk, Dan Hoffman, at (202) 357-

6360.

IT IS SO ORDERED.

s/Christian J. Moran

Christian J. Moran

Special Master

 

2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each 

party filing a notice renouncing the right to seek review by a United States Court of Federal 

Claims judge.
104TH CONGRESS

1ST SESSION S. 212

AN ACT

To authorize the Secretary of Transportation to issue a

certificate of documentation with appropriate endorsement for employment in the coastwise trade for the vessel

SHAMROCK V.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That notwithstanding sections 12106, 12107, and 12108

4 of title 46, United States Code, and section 27 of the Mer5 chant Marine Act, 1920 (46 App. U.S.C. 883), as applica6 ble on the date of enactment of this Act, the Secretary

7 of Transportation may issue a certificate of documentation

8 with appropriate endorsement for employment in the

9 coastwise trade for the vessel SHAMROCK V (United

10 States official number 900936).

Passed the Senate July 29, 1996.

Attest:

Secretary.
104TH CONGRESS

1ST SESSION S. 212

AN ACT

To authorize the Secretary of Transportation to

wise trade for the vessel SHAMROCK V.priate endorsement for employment in the coastissue a certificate of documentation with appro-
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1931 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 1931

 To provide that the United States Post Office building that is to be 
 located at 9 East Broad Street, Cookeville, Tennessee, shall be known 
 and designated as the ``L. Clure Morton Post Office and Courthouse''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              July 8, 1996

Mr. Thompson (for himself and Mr. Frist) introduced the following bill; 
  which was read twice and referred to the Committee on Governmental 
                                Affairs

_______________________________________________________________________

                                 A BILL

 
 To provide that the United States Post Office building that is to be 
 located at 9 East Broad Street, Cookeville, Tennessee, shall be known 
 and designated as the ``L. Clure Morton Post Office and Courthouse''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION OF L. CLURE MORTON POST OFFICE AND COURTHOUSE.

    The United States Post Office building that is to be located at 9 
East Broad Street, Cookeville, Tennessee, shall be known and designated 
as the ``L. Clure Morton Post Office and Courthouse''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the United States Post Office building 
referred to in section 1 shall be deemed to be a reference to the ``L. 
Clure Morton Post Office and Courthouse''.
                                 <all>
```
Re: HPV 2 Clariant submission of Test Data to satisfy TR Requirements 

CASRN 6624-11-0 

Bob Boethling to: Paul Campanella 06/27/2012 10:34 PM

Cc: Chuantung Lin, John Schaeffer, Kathryn Schechter, Marcus Aguilar

I reviewed the biodegradation study (OECD 301F method) submitted for this substance. The test was 

correctly run and the results are deemed reliable. The substance did not biodegrade, which was 

expected.

Robert Boethling, PhD

Exposure Assessment Branch

US EPA, Office of Pollution Prevention and Toxics

1200 Pennsylvania Ave, NW (7406M)

Washington, DC 20460

202-564-8533 (P)

202-564-8892 (F) 

[EPI Suite] http://www.epa.gov/opptintr/exposure/pubs/episuite.htm

[FatePointer] http://esc.syrres.com/fatepointer/search.asp

Paul Campanella Daniel and Bob, attached are the pdf's submitted... 06/27/2012 04:41:23 PM

From: Paul Campanella/DC/USEPA/US

To: Chuantung Lin/DC/USEPA/US, Bob Boethling/DC/USEPA/US@EPA

Cc: John Schaeffer/DC/USEPA/US@EPA, Marcus Aguilar/DC/USEPA/US, Kathryn 

Schechter/DC/USEPA/US@EPA

Date: 06/27/2012 04:41 PM

Subject: HPV 2 Clariant submission of Test Data to satisfy TR Requirements CASRN 6624-11-0

Daniel and Bob, attached are the pdf's submitted by Clariant to satisfy requirements under the test rule. 

Please review.

[attachment "Reach dossier of LSB-1 July 2010.pdf" deleted by Bob Boethling/DC/USEPA/US] 

[attachment "A1Freeze Pt.pdf" deleted by Bob Boethling/DC/USEPA/US] [attachment "A2 BP.pdf" deleted 

by Bob Boethling/DC/USEPA/US] [attachment "A3 VP.pdf" deleted by Bob Boethling/DC/USEPA/US] 

[attachment "A4 Octonal Water.pdf" deleted by Bob Boethling/DC/USEPA/US] [attachment "A5 Water 

sol.pdf" deleted by Bob Boethling/DC/USEPA/US] [attachment "B Biodeg.pdf" deleted by Bob 

Boethling/DC/USEPA/US] 

Paul J. Campanella, Ph.D.

Chemical Information and Testing Branch

Chemical Control Division

U.S. Environmental Protection Agency

Washington, D.C. 

202-564-8091
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markm an Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra

, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

_________________________________________ Clerk July 24, 2012

h0716 

# Order

July 24, 2012

142875

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 142875

COA: 295497

Ottawa CC: 09

- 033711

- FH

BENJAMIN CURTIS WALBURG,

Defendant

- Appellant.

_________________________________________/

By order of June 22, 2011, the application for leave to appeal the February 10,

2011 judgment of the Court of Appeals was held in abeyance pending the decisions in

People v Kolanek (Docket Nos. 142695, 142712) and People v King (Docket No.

142850). On ord er of the Court, the cases having been decided on May 31, 2012, 491

Mich ___ (2012), the application is again considered, and it is DENIED, because we are

not persuaded that the question presented should be reviewed by this Court.
[Federal Register Volume 89, Number 21 (Wednesday, January 31, 2024)]
[Notices]
[Page 6121]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01848]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive and 
Kidney Diseases Special Emphasis Panel; NIDDK RC2 Application Review.
    Date: February 29, 2024.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Cheryl Nordstrom, Ph.D., M.Ph., Scientific Review 
Officer, NIDDK/Scientific Review Branch, National Institutes of Health, 
6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-402-6711, 
<a href="/cdn-cgi/l/email-protection#593a313c2b20357737362b3d2a2d2b363419373031773e362f"><span class="__cf_email__" data-cfemail="6102090413180d4f0f0e13051215130e0c210f08094f060e17">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: January 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01848 Filed 1-30-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1612 Referred in House (RFH)]

104th CONGRESS
  2d Session
                                S. 1612

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 4, 1996

               Referred to the Committee on the Judiciary

_______________________________________________________________________

                                 AN ACT

 
   To broaden the scope of certain firearms offenses, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FIREARMS OFFENSES.

    (a) In General.--Sections 924(c)(1) and 929(a)(1) of title 18, 
United States Code, are each amended by striking ``uses or carries'' 
and inserting ``possesses''.
    (b) Amendment of Sentencing Guidelines.--
            (1) In general.--Pursuant to its authority under section 
        994 of title 28, United States Code, the United States 
        Sentencing Commission shall review and, if appropriate, amend 
        the Federal Sentencing Guidelines and the policy statements of 
        the Commission to provide an appropriate sentence enhancement 
        with respect to any defendant who discharges a firearm during 
        or in relation to any crime of violence or any drug trafficking 
        crime.
            (2) Consistency.--In carrying out this subsection, the 
        United States Sentencing Commission shall--
                    (A) ensure that there is reasonable consistency 
                with other Federal Sentencing Guidelines;
                    (B) avoid duplicative punishment for substantially 
                the same offense; and
                    (C) take into account any mitigating circumstances 
                that might justify an exception to any amendment made 
                under paragraph (1).
            (3) Definitions.--For purposes of this subsection, the 
        terms ``crime of violence'' and ``drug trafficking crime'' have 
        the same meanings as in section 924(c) of title 18, United 
        States Code.

            Passed the Senate October 3, 1996.

            Attest:

                                                    GARY SISCO,

                                                             Secretary.
```
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<EXCHANGE-RATE>                                      1
<CASH>                                          22,832
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     29,744
<CURRENT-ASSETS>                                52,651
<PP&E>                                          39,640
<DEPRECIATION>                                   4,724
<TOTAL-ASSETS>                                  92,291
<CURRENT-LIABILITIES>                          171,694
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        58,549
<OTHER-SE>                                   (256,832)
<TOTAL-LIABILITY-AND-EQUITY>                    92,291
<SALES>                                          1,495
<TOTAL-REVENUES>                                 1,495
<CGS>                                              317
<TOTAL-COSTS>                                  513,176
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,936
<INCOME-PRETAX>                              (513,176)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (513,176)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (513,176)
<EPS-PRIMARY>                                   (0.09)
<EPS-DILUTED>                                   (0.09)
        

</TABLE>
<PAGE>   1

EXHIBIT 21.1 -- LIST OF SUBSIDIARIES OF THE REGISTRANT

At December 31, 1999, the Registrant owned all of the issued and outstanding
capital stock of (1) Great Bay Power Corporation, a New Hampshire corporation,
(2) Little Bay Power Corporation, a New Hampshire corporation, and (3)
HoustonStreet Exchange, Inc., a Delaware corporation. As of March 27, 2000, the
Registrant owned approximately 53% of the issued and outstanding capital stock
of HoustonStreet Exchange, Inc. (giving effect to the conversion into
HoustonStreet Common Stock of all issued and outstanding shares of HoustonStreet
Preferred Stock convertible into HoustonStreet Common Stock).

Great Bay Power Corporation conducts business only under the business name of
Great Bay Power Corporation. Little Bay Power Corporation conducts business only
under the business name of Little Bay Power Corporation. HoustonStreet Exchange,
Inc. conducts business only under the names HoustonStreet Exchange, Inc.,
HoustonStreet and HoustonStreet.com.
RIA to OMB 3-5-10